BinaxNOW COVID-19 Antigen Self Test (2 ct.)


BinaxNOW COVID 19 Antigen Self-Test (2 ct.)


About this item

Requires just a shallow nasal swab that you can do yourself

Convenient, fast results anytime, anywhere

Detects multiple strains, including the Delta & Omicron variants*

BinaxNOW Self Test uses the same technology used by doctors

Includes 2 tests so you can test yourself twice within 3 days


In stock

Secure Payment With:

Social Sharing:

BinaxNOW COVID-19 Antigen Self-Test (2 ct.)



BinaxNOW COVID-19 Antigen Self-Test (2 Tests) is a simple solution for COVID-19 infection detection, with rapid results in the convenience of your home. This test has received FDA Emergency Use Authorization for self-testing without the need to ship samples to a lab or for a prescription from your healthcare provider. This 15-minute test can be completed anytime, anywhere. Simply test yourself twice within 3 days, with at least 36 hours between tests.


BinaxNOW COVID 19 Antigen Self-Test (2 ct.)

  • Get results in 15 minutes
  • Detects active COVID-19 infection
  • Includes illustrated step-by-step instructions
  • Perform simple test procedure using a minimally invasive nasal swab
  • Know your result now, without a need to wait for results from your healthcare provider


How To Use

  1. Prepare for the test.
  2. Collect nasal sample, or help others administer if they require
  3. assistance
  4. Perform the test.
  5. See results after 15 minutes
  6. Test again within three days (with at least 36 hours between tests)


Refer to the product insert for full instructions.


This test does NOT meet the CDC testing requirements to enter the U.S. when returning from a trip abroad.


The self-test is indicated for children as young as 2 years old when samples are collected by an adult, and for all people 15 and older. The BinaxNOW COVID-19 Antigen Self-Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self-Test should be performed twice in 3 days, at least 36 hours apart. 2021 Abbott. All rights reserved. BinaxNOW is a trademark of Abbott and used with permission. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model.